| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/16/2008 | US7425413 Methods of designing, synthesizing, and propagating reference nucleic acids |
| 09/16/2008 | US7425412 Determining whether a naturally occurring strain of algae is toxic, comprisingdetermining whether a sample obtained from said strain of algae comprises a nucleic acid encoding a specific polypeptide; harmful algal blooms; shellfish; gene expression |
| 09/16/2008 | US7425327 Choline binding proteins for anti-pneumococcal vaccines |
| 09/16/2008 | US7425308 Systems for the active electronic control of biological reactions |
| 09/16/2008 | CA2410888C Nucleic acid isolation |
| 09/12/2008 | WO2008109837A2 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell |
| 09/12/2008 | WO2008109833A2 Polynucleotides and polypeptides identified by iviat screening and methods of use |
| 09/12/2008 | WO2008109688A1 Method and apparatus of dna-coupled lateral-flow assay (dna-clfa) |
| 09/12/2008 | WO2008109558A2 Nucleic acid compounds for inhibiting tlr gene expression and uses thereof |
| 09/12/2008 | WO2008109555A2 Nucleic acid compounds for inhibiting nrg1 gene expression and uses thereof |
| 09/12/2008 | WO2008109548A2 Nucleic acid compounds for inhibiting tgfb gene expression and uses thereof |
| 09/12/2008 | WO2008109532A2 Nucleic acid compounds for inhibiting fas gene expression and uses thereof |
| 09/12/2008 | WO2008109531A2 Nucleic acid compounds for inhibiting hsd11b1 expression and uses thereof |
| 09/12/2008 | WO2008109520A2 Nucleic acid compounds for inhibiting cxc gene expression and uses thereof |
| 09/12/2008 | WO2008109500A2 Nucleic acid compounds for inhibiting prkca gene expression and uses thereof |
| 09/12/2008 | WO2008109498A2 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof |
| 09/12/2008 | WO2008109493A2 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof |
| 09/12/2008 | WO2008109490A2 Nucleic acid compounds for inhibiting chek1 gene expression and uses thereof |
| 09/12/2008 | WO2008109487A2 Nucleic acid compounds for inhibiting mme gene expression and uses thereof |
| 09/12/2008 | WO2008109472A2 Nucleic acid compounds for inhibiting pcsk9 gene exprression and uses thereof |
| 09/12/2008 | WO2008109470A2 Nucleic acid compounds for inhibiting ptpn1 gene expression and uses thereof |
| 09/12/2008 | WO2008109469A2 Nucleic acid compounds for inhibiting pcna gene expression and uses thereof |
| 09/12/2008 | WO2008109460A2 Nucleic acid compounds for inhibiting ctnnb1 gene expression and uses thereof |
| 09/12/2008 | WO2008109450A2 Nucleic acid compounds for inhibiting id-1 gene expression and uses thereof |
| 09/12/2008 | WO2008109443A2 Nucleic acid compounds for inhibiting cdk2 gene expression and uses thereof |
| 09/12/2008 | WO2008109380A2 Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof |
| 09/12/2008 | WO2008109378A2 Nucleic acid compounds for inhibiting pdgfr gene expression and uses thereof |
| 09/12/2008 | WO2008109372A2 Nucleic acid compounds for inhibiting pdgf gene expression and uses thereof |
| 09/12/2008 | WO2008109366A2 Nucleic acid compounds for inhibiting ccnd1 gene expression and uses thereof |
| 09/12/2008 | WO2008109364A2 Nucleic acid compounds for inhibiting frap1 gene expression and uses thereof |
| 09/12/2008 | WO2008109350A2 Nucleic acid compounds for inhibiting il6 gene expression and uses thereof |
| 09/12/2008 | WO2008108877A2 Specific lysis of staphylococcal pathogens by bacteriophage phi1 1 endolysin |
| 09/12/2008 | WO2008106803A1 Double-stranded locked nucleic acid compositions |
| 09/12/2008 | WO2008106796A1 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity |
| 09/12/2008 | WO2008106785A1 Assessment of risk for colorectal cancer |
| 09/12/2008 | WO2008106709A1 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS |
| 09/12/2008 | WO2008079469A3 Genetically engineered biological indicator |
| 09/12/2008 | WO2008070074A3 Genetic markers of schizophrenia |
| 09/12/2008 | WO2008039357A3 Uncoupling of dna insert propagation and expression of protein for phage display |
| 09/12/2008 | WO2007133183A3 Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors |
| 09/12/2008 | WO2007127801A3 Hepatitis c virus infection biomarkers |
| 09/12/2008 | WO2006076041A3 Pan-her antagonists and methods of use |
| 09/12/2008 | WO2006038908A3 Ancestral and cot viral sequences, proteins and immunogenic compositions |
| 09/12/2008 | CA2680129A1 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell |
| 09/12/2008 | CA2680121A1 Primers for melting analysis |
| 09/12/2008 | CA2680060A1 Double-stranded locked nucleic acid compositions |
| 09/12/2008 | CA2680058A1 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity |
| 09/12/2008 | CA2679954A1 Assessment of risk for colorectal cancer |
| 09/12/2008 | CA2679943A1 Multigene assay to predict outcome in an individual with glioblastoma |
| 09/12/2008 | CA2679045A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 09/12/2008 | CA2678799A1 Methods and kits for amplifying dna |
| 09/11/2008 | US20080222742 Plasmid comprising ribosmal protein promoter sequences for use as tool in controlling and enhancing genic expression in transgenic cells; biodrug |
| 09/11/2008 | US20080222740 Improved properties such as temperature and/or pH stability, pH activity profile, temperature activity profile, substrate profile, improved performance in animal feed in vitro or in vivo |
| 09/11/2008 | US20080221317 siRNA targeting cystic fibrosis transmembrane conductance regulator (CFTR) |
| 09/11/2008 | US20080221316 Short interfering RNA sequences for use in treatment and prevention of cell proliferative, diabetic and nervous system disorders |
| 09/11/2008 | US20080221315 Nucleic acid-based translation system and method for decoding nucleic acid encrypted message |
| 09/11/2008 | US20080221305 Polynucleotides encoding novel adiponectin receptor variants |
| 09/11/2008 | US20080221240 Functionalization of nanoscale articles including nanotubes and fullerenes |
| 09/11/2008 | US20080221059 Novel treatment tool for cancer: rna interference of bcas2 |
| 09/11/2008 | US20080221055 Compositions and methods for inhibiting expression of huntingtin gene |
| 09/11/2008 | US20080221054 In vitro; transgenic cells, mammals; kits |
| 09/11/2008 | US20080221053 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals; selectively bind coagulation factors, E2F family members, Ang1 or Ang2 |
| 09/11/2008 | US20080221050 Genetic polymorphisms linked to optic neuropathy including glaucoma and Leber's disease; point mutations; enothelins; angiotensins; gene expression inhibition |
| 09/11/2008 | US20080221034 Canine specific growth hormone releasing hormone |
| 09/11/2008 | US20080221021 Novel Corticotropin-Releasing Factor Receptor 1 (Crfr1) Agonist |
| 09/11/2008 | US20080221012 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
| 09/11/2008 | US20080221011 CR2-FH C-reactive protein, factor H fusion protein; inhibiting complement activation of the alternative pathway |
| 09/11/2008 | US20080220981 Chimeric binding peptide library screening method |
| 09/11/2008 | US20080220519 Mutated e. coli heat-labile enterotoxin |
| 09/11/2008 | US20080220503 Screening method for genes of brewing yeast |
| 09/11/2008 | US20080220487 Biosynthesis; bioreduction; biocatalysts; enhanced enantioselectivity for (S)-enantiomer substrate catalytic activity |
| 09/11/2008 | US20080220479 Expression vector comprising nucleotide sequences coding cytokine receptor specific immunoglobulin for treatment and prevention of inflammation, cartilage degradation and bone resorption |
| 09/11/2008 | US20080220476 Thermostable Alpha-Amylases |
| 09/11/2008 | US20080220475 mTOR LIGANDS AND POLYNUCLEOTIDES ENCODING mTOR LIGANDS |
| 09/11/2008 | US20080220473 Endo-N-Acetyl-Beta-D-Glucosaminidase Enzymes of Filamentous Fungi |
| 09/11/2008 | US20080220471 Nucleotide sequences coding Tet repressor (TetR) protein for use as gene targeting tool in genetic engineering |
| 09/11/2008 | US20080220460 Modified flavin adenine dinucleotide dependent glucose dehydrogenase |
| 09/11/2008 | US20080220455 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR |
| 09/11/2008 | US20080220423 Using cyclic amplification of nucleotide sequences to generate probes for use in detecting splice variants, single transcripts, deletions and duplications in preferential exons |
| 09/11/2008 | US20080220419 Oligonucleotide primers/probes; cytochrome p450 monooxygenase enzyme system; expression vectors; kits |
| 09/11/2008 | US20080220417 Novel Alanine Transaminase Enzymes and Methods of Use |
| 09/11/2008 | US20080220072 Biologic modulations with nanoparticles |
| 09/11/2008 | US20080220027 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 09/11/2008 | US20080220011 Flagellin/tumor antigen fusion for use in induction of immune response to cancer antigen; tissue targeted therapy; antitumor agents |
| 09/11/2008 | US20080220009 Composition comprising hepadnavirus core antigen for use in preparing vaccines against hepatitis infection |
| 09/11/2008 | US20080220002 Modified transferin-antibody fusion proteins |
| 09/11/2008 | US20080219998 Anticoagulant for use in treatment and prevention of thrombosis or thrombin-dependent vaso-occlusive disease; selective reduction of intravascular thromboplastin antecedent activity |
| 09/11/2008 | US20080219997 Her-2 binding antagonists |
| 09/11/2008 | US20080219991 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219989 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219986 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 09/11/2008 | US20080219984 Nucleotide sequences coding myelin-associated glycoprotein receptor for use in identifying modulators for treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 09/11/2008 | US20080219981 Solid cancer antigenic polypeptide for use in designing and identifying modulators for prevention and treatment of tumorous masses |
| 09/11/2008 | US20080219974 Transmembrane glycoprotein specific immunoglobulin for use in diagnosis, prevention and treatment of autoimmune diseases |
| 09/11/2008 | US20080219972 Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer |
| 09/11/2008 | US20080219971 Leukocyte semaphorin specific immunoglobulin for use in prevention and treatment of inflammation, autoimmune, skin, nervous system and/or cell roliferative disorders |
| 09/11/2008 | US20080219970 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands |
| 09/11/2008 | US20080219968 Son of sevenless homolog 1 (SOS1) suppressive agent for prevention and treatment of cell proliferative disorders |